Market Segmentation
The MRFR report offers an inclusive segmental analysis of the global vascular stents market report based on end user, material, and type.
By type, the global vascular stents market is segmented into evar stent grafts, peripheral stents, and coronary stents. Peripheral stents are again segmented into iliac artery stents, femoral artery stents, renal artery stents, carotid artery stents, and others. Evar stent grafts are again segmented into thoracic aortic aneurysm stents and abdominal aortic aneurysm stents.
The MRFR report offers an inclusive segmental analysis of the global vascular stents market report based on end user, material, and type.
Various factors are propelling the global vascular stents market growth. As per the latest MRFR report, such factors include short recovery time, low risk of infection, increasing obese population, and technological advancements.
The global vascular stents market had been valued at USD 7.7% CAGR in 2018 and is predicted to grow at a healthy 7.7% CAGR between 2019- 2025, as per the recent analysis by Market Research Future (MRFR). Vascular stents, simply put, are small tube-like medical devices that are placed into arteries or blood vessels to open any blockage in the vessel. It is a valuable tool to treat various forms of coronary diseases and used to widen narrow vessels to prevent chest pain and heart attack.
Increasing spending in healthcare research, rising preference for minimally invasive procedures in Canada and the US, high adoption of new technology, and rising cases of vascular diseases are adding to the global vascular stents market growth in the region.
The global vascular stents market in Europe is predicted to hold the second-largest share over the forecast period. The involvement of top companies, innovations in stenting technologies, and the presence of an established healthcare system are adding to the vascular stents market growth in the region.
The global vascular stents market in the APAC region is predicted to grow at a fast pace over the forecast period. Rapid growth in the geriatric population, coupled with increasing cases of vascular disease, is adding to the global vascular stents market growth in the region.
The global vascular stents market in the MEA is predicted to have the smallest share during the forecast period due to the low per capita disposable income.
The global Non-Vascular Stents Market size is expected to value at USD 1.4 billion by 2025.
Furthermore, growing importance towards minimally invasive surgeries across the globe is expected to drive growth of the market in upcoming years.Increasing incidences related to the gastrointestinal cancer across the globe, is further propelling demand for non-vascular stents.
Globally, the market is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the non-vascular stents industry.Geriatric population is more susceptible towards chronic diseases including lung cancer, pancreatic cancer, colorectal cancer, and other diseases such as stroke, asthma.
Subsequently, increasing incidences related to chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma, are responsible for rising demand of non-vascular stents.For further inquiries, about - Global Non-vascular Stents Industry Analysis, Size, Growth, Trends and Forecast 2014 - 2025, click on this link – https://www.millioninsights.com/industry-reports/non-vascular-stents-marketAs per reports by World Health Organization (WHO), geriatric population is expected to reach two billion by 2050.
The minimally invasive techniques performed by tiny incisions instead of one large opening as they offer advantages such as quicker recovery times and less discomfort over traditional surgery.
Additional advantages associated with adoption of minimally invasive techniques includes reduced pain during the surgery and minimum surgical scars.
Vascular Stents Market: IntroductionAccording to the report, the global vascular stents market was valued at US$ 7.6 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.
Drug eluting stents (DES) are comparatively newer to bare metal stents (BMS) and have been able to capture the latter’s market share of the global vascular stents market to become market leader.
Peripheral vascular stents segment is further divided into sub-segments, including fem-pop artery stents, iliac artery stents, and infrapop artery stents.
According to the European Heart Network, CVD causes 3.9 million deaths in Europe each year.Self-expanding Stents to be Highly AttractiveIn terms of delivery method, the global vascular stents market has been classified into balloon expandable stents and self-expanding stents.
Self-expanding stents offer improved clinical outcomes, as they induce less injury at implantation and achieve better vessel wall apposition.Request Customization on Vascular Stents Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=8191 Cobalt-Chromium Stent to Account for Major ShareBased on material, the global vascular stents market has been categorized into cobalt-chromium stent, platinum-chromium stent, nitinol stent, stainless steel stent, and bioresorbable polymer stent.
Advantages offered by cobalt chromium, such as strength, non-ferromagnetism, biocompatibility, and high resistance to corrosion and fatigue are expected to increase the usage of cobalt chromium for stents during the forecast period.
Global Vascular Stents Market Research Report - Forecast to 2023” – Market Analysis, Scope, Progress, Trends and Forecast to 2023.
Vascular stent is the valuable tool for the treatment of the different coronary diseases.
Vascular stents are used to widen the narrow vessels so as to minimize the chances of heart attack and chest pain.
According to the WHO, approximately 18 million people died from cardiovascular diseases in 2014.
Increasing number of people suffering from cardiovascular diseases is responsible for the driving the market.
However availability of alternative therapy and high cost of ventricular stents may restrain the growth of the market.
